Characteristics of Potential Protein Nutraceuticals of Plant Origin with Antioxidant Activity
Abstract
:1. Introduction
2. Results
2.1. Characteristics of Plant Proteins as Precursors of Bioactive Fragments with Antioxidant Activity
2.1.1. Profiling Wheat Proteins in Terms of Antioxidant Activity
2.1.2. Profiling Rice Proteins in Terms of Antioxidant Activity
2.1.3. Profiling Barley and Oat Proteins in Terms of Antioxidant Activity
2.1.4. Profiling Buckwheat, Rye and Sorghum Proteins in Terms of Antioxidant Activity
2.2. In Silico Hydrolysis of Selected Plant Proteins with the use of Selected Enzymes (BIOPEP-UWM)
2.2.1. Bioevaluation of Wheat Protein Proteolysis Simulation Process and Products
2.2.2. Bioevaluation of the Rice Protein Proteolysis Simulation Process and Products
2.2.3. Bioevaluation of the Barley and Oat Protein Proteolysis Simulation Process and Products
2.2.4. Bioevaluation of the Buckwheat, Rye and Sorghum Protein Proteolysis Simulation Process and Products
3. Discussion
3.1. Plant Proteins as Precursors of Bioactive Fragments with Antioxidant Activity
3.2. Bioevaluation of the Plant Protein Proteolysis Simulation Process and Products
4. Materials and Methods
4.1. Materials
4.2. Methods
4.2.1. Characteristics of Plant Proteins as Precursors of Bioactive Fragments with Antioxidant Activity
Profiles of Potential Antioxidant Activity of Selected Plant Proteins
Calculation of the Bioparameters Characterising the Antioxidant Activity of Selected Plant Proteins
4.2.2. In Silico Hydrolysis of Selected Plant Proteins with the use of Selected Enzymes (BIOPEP-UWM)
Characteristics of Antioxidant Peptides Obtained from the Performed Proteolysis Simulation
Bioevaluation of the Proteolysis Simulation Process and Products
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- Singh, J.; Sinha, S. Classification, regulatory acts and applications of nutraceuticals for health. Int. J. Pharm. Biol. Sci. 2012, 2, 177–187. [Google Scholar]
- Nasri, H.; Baradaran, A.; Shirzad, H.; Rafieian-Kopaei, M. New concepts in nutraceuticals as alternative for pharmaceuticals. Int. J. Prev. Med. 2014, 5, 1487–1499. [Google Scholar] [PubMed]
- Chaudhari, S.P.; Powar, P.V.; Pratapwar, M.N. Nutraceuticals: A review. World J. Pharm. Pharm. Sci. 2017, 6, 681–739. [Google Scholar] [CrossRef] [Green Version]
- Prasad, S.; Gupta, S.C.; Tyagi, A.K. Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals. Cancer Lett. 2017, 387, 95–105. [Google Scholar] [CrossRef] [PubMed]
- Manzanares, P.; Gandía, M.; Garrigues, S.; Marcos, J.F. Improving health-promoting effects of food-derived bioactive peptides through rational design and oral delivery strategies. Nutrients 2019, 11, 2545. [Google Scholar] [CrossRef] [Green Version]
- Pavan, R.; Jain, S.; Shraddha; Kumar, A. Properties and therapeutic application of bromelain: A review. Biotechnol. Res. Int. 2012, 2012, 1–6. [Google Scholar] [CrossRef] [Green Version]
- Baidamshina, D.R.; Trizna, E.Y.; Holyavka, M.G.; Bogachev, M.I.; Artyukhov, V.G.; Akhatova, F.S.; Rozhina, E.V.; Fakhrullin, R.F.; Kayumov, A.R. Targeting microbial biofilms using ficin, a nonspecific plant protease. Sci. Rep. 2017, 7, 1–12. [Google Scholar] [CrossRef] [Green Version]
- Zhao, L.; Budge, S.M.; Ghaly, A.E.; Brooks, M.S.; Dave, D. Extraction, purification and characterization of fish pepsin: A critical review. J. Food Process. Technol. 2011, 2, 1–14. [Google Scholar] [CrossRef] [Green Version]
- Park, Y.W.; Nam, M.S. Bioactive peptides in milk and dairy products: A review. Korean J. Food Sci. Ann. 2015, 35, 831–840. [Google Scholar] [CrossRef] [Green Version]
- Bhat, Z.F.; Kumar, S.; Bhat, H.F. Bioactive peptides from egg: A review. Nutr. Food Sci. 2015, 45, 190–212. [Google Scholar] [CrossRef]
- Möller, N.P.; Scholz-Ahrens, K.E.; Roos, N.; Schrezenmeir, J. Bioactive peptides and proteins from foods: Indication for health effects. Eur. J. Nutr. 2008, 47, 171–182. [Google Scholar] [CrossRef] [PubMed]
- Morato, P.N.; Lollo, P.C.; Moura, C.S.; Batista, T.M.; Carneiro, E.M.; Amaya-Farfan, J. A dipeptide and an amino acid present in whey protein hydrolysate increase translocation of GLUT-4 to the plasma membrane in Wistar rats. Food Chem. 2013, 139, 853–859. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, X.; Yu, H.; Xing, R.; Liu, S.; Chen, X.; Li, P. Preparation and identification of antioxidative peptides from pacific herring (Clupea pallasii) protein. Molecules 2019, 24, 1946. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Korczek, K.; Tkaczewska, J.; Migdał, W. Antioxidant and antihypertensive protein hydrolysates in fish products–A review. Czech, J. Food Sci. 2018, 36, 195–207. [Google Scholar] [CrossRef] [Green Version]
- Food and Agriculture Organization of the United Nations/World Health Organization. Protein quality evaluation: Report of the Joint FAO/WHO Expert Consultation, FAO Food and Nutrition Paper 51; Food and Agriculture Organization of the United Nations: Rome, Italy, 1991. [Google Scholar]
- Food and Agriculture Organization of the United Nations/World Health Organization. Dietary Protein Quality Evaluation in Human Nutrition, FAO Food and Nutrition Paper 92; Report of an FAO Expert Consultation: Rome, Italy, 2013. [Google Scholar]
- Schaafsma, G. Advantages and limitiations of the protein digestibility-corrected amino acid score (PDCAAS) as a method for evaluating protein quality in human diets. Br. J. Nutr. 2012, 108, S333–S336. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rutherfurd, S.M.; Fanning, A.C.; Miller, B.J.; Moughan, P.J. Protein digestibility-corrected amono acid scores differentially describe protein quality in growing male rats. J. Nutr. 2015, 145, 372–379. [Google Scholar] [CrossRef] [Green Version]
- Wolfe, R.R.; Rutherfurd, S.M.; Kim, I.-Y.; Moughan, P.J. Protein quality as determined by the Digestible Indispensable Amino Acid Score: Evaluation of factors underlying the calculation. Nutr. Rev. 2016, 74, 584–599. [Google Scholar] [CrossRef]
- Minkiewicz, P.; Iwaniak, A.; Darewicz, M. BIOPEP-UWM database of bioactive peptides: Current opportunities. Int. J. Mol. Sci. 2019, 20, 5978. [Google Scholar] [CrossRef] [Green Version]
- Minkiewicz, P.; Dziuba, J.; Iwaniak, A.; Dziuba, M.; Darewicz, M. BIOPEP database and other programs for processing bioactive peptide sequences. J. AOAC Int. 2008, 91, 965–980. [Google Scholar] [CrossRef] [Green Version]
- Agyei, D.; Tsopmo, A.; Udenigwe, C.C. Bioinformatic and peptidomic approaches to the discovery and analysis of food-derived bioactive peptides. Anal. Bioanal. Chem. 2018, 410, 3463–3472. [Google Scholar] [CrossRef]
- Tu, M.; Cheng, S.; Lu, W.; Du, M. Advancement and prospects of bioinformatics analysis for studying bioactive peptides from food-derived protein: Sequence, structure, and functions. Trends Anal. Chem. 2018, 105, 7–17. [Google Scholar] [CrossRef]
- Piovesana, S.; Capriotti, A.L.; Cavaliere, C.; La Barbera, G.; Montone, C.M.; Zenezini Chiozzi, R.; Laganà, A. Recent trends and analytical challenges in plant bioactive peptide separation, identification and validation. Anal. Bioanal. Chem. 2018, 410, 3425–3444. [Google Scholar] [CrossRef] [PubMed]
- Bekhit, A.A.; Hopkins, D.L.; Geesink, G.; Bekhit, A.A.; Franks, P. Exogenous proteases for meat tenderization. Crit. Rev. Food Sci. Nutr. 2014, 54, 1012–1031. [Google Scholar] [CrossRef] [PubMed]
- Ha, M.; Bekhit, A.A.; Carne, A.; Hopkins, D.L. Characterisation of commercial papain, bromelain, actinidin and zingibain protease preparations and their activities toward meat proteins. Food Chem. 2012, 134, 95–105. [Google Scholar] [CrossRef]
- Sánchez, A.; Vázquez, A. Bioactive peptides: A review. Food Qual. Safet. 2017, 1, 29–46. [Google Scholar] [CrossRef]
- Iwaniak, A.; Darewicz, M.; Minkiewicz, P. Peptides derived from foods as supportive diet components in the prevention of metabolic syndrome. Compr. Rev. Food Sci. Food Saf. 2018, 17, 63–81. [Google Scholar] [CrossRef] [Green Version]
- Szerszunowicz, I.; Nałęcz, D. The use of UniProtKB/BIOPEP for the analysis of oat globulin physicochemical parameters and bioactivity. Czech J. Food Sci. 2018, 36, 119–125. [Google Scholar] [CrossRef] [Green Version]
- Esfandi, R.; Walters, M.E.; Tsopmo, A. Antioxidant properties and potential mechanisms of hydrolyzed proteins and peptides from cereals. Heliyon. 2019, 5, 1–26. [Google Scholar] [CrossRef] [Green Version]
- Klose, C.; Arendt, E.K. Proteins in oats; their synthesis and changes during germination: A review. Crit. Rev. Food Sci. Nutr. 2012, 52, 629–639. [Google Scholar] [CrossRef]
- Boeck, T.; D’Amico, S.; Zechner, E.; Jaeger, H.; Schoenlechner, R. Nutritional properties of various oat and naked oat cultivars. Die Bodenkultur J. Land Manag. Food Environ. 2018, 69, 215–226. [Google Scholar] [CrossRef] [Green Version]
- Rasane, P.; Jha, A.; Sabikhi, L.; Kumar, A.; Unnikrishnan, V.S. Nutritional advantages of oats and opportunities for its processing as value added foods-a review. J Food Sci. Technol. 2015, 52, 662–675. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- De Mesa-Stonestreet, N.J.; Alavi, S.; Bean, S.R. Sorghum proteins: The concentration, isolation, modification, and food applications of kafirins. J. Food Sci. 2010, 75, R90–R104. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Xiao, J.; Li, Y.; Li, J.; Gonzalez, A.P.; Xia, Q.; Huang, Q. Structure, morphology, and assembly behavior of kafirin. J. Agric. Food Chem. 2015, 63, 216–224. [Google Scholar] [CrossRef] [Green Version]
- Xiao, J.; Chen, Y.; Huang, Q. Physicochemical properties of kafirin protein and its applications as building blocks of functional delivery systems. Food Funct. 2017, 8, 1402–1413. [Google Scholar] [CrossRef]
- Zhang, P.; Ma, G.; Wang, C.; Lu, H.; Li, S.; Xie, Y.; Ma, D.; Zhu, Y.; Guo, T. Effect of irrigation and nitrogen application on grain amino acid composition and protein quality in winter wheat. PLoS ONE 2017, 12, 1–15. [Google Scholar] [CrossRef] [PubMed]
- Suárez López, M.M.; Kizlansky, A.; López, L.B. Evaluacion de la calidad de las proteinas en los Alimentos calculando el escore de aminoacidos corregido por digestibilidad. Nutr. Hosp. 2006, 21, 47–51. [Google Scholar]
- Chen, H.-M.; Muramoto, K.; Yamauchi, F.; Nokihara, K. Antioxidant activity of designed peptides based on the antioxidant peptide isolated from digests of a soybean protein. J. Agric. Food Chem. 1996, 44, 2619–2623. [Google Scholar] [CrossRef]
- Chen, H.-M.; Muramoto, K.; Yamauch, F. Structural analysis of antioxidative peptides from soybean beta-conglycynin. J. Agric. Food Chem. 1995, 43, 574–578. [Google Scholar] [CrossRef]
- De Gobba, C.; Tompa, G.; Otte, J. Bioactive peptides from caseins released by cold active proteolytic enzymes from Arsukibacterium ikkense. Food Chem. 2014, 165, 205–215. [Google Scholar] [CrossRef]
- Ohata, M.; Uchida, S.; Zhou, L.; Arihara, K. Antioxidant activity of fermented meat sauce and isolation of an associated antioxidant peptide. Food Chem. 2016, 194, 1034–1039. [Google Scholar] [CrossRef]
- Suetsuna, K.; Ukeda, H.; Ochi, H. Isolation and characterization of free radical scavenging activities peptides derived from casein. J. Nutr. Biochem. 2000, 11, 128–131. [Google Scholar] [CrossRef]
- Hernández-Ledesma, B.; Quiros, A.; Amigo, L.; Recio, I. Identification of bioactive peptides after digestion of human milk and infant formula with pepsin and pancreatin. Int. Dairy J. 2007, 17, 42–49. [Google Scholar] [CrossRef]
- Beermann, C.; Euler, M.; Herzberg, J.; Stahl, B. Anti-oxidative capacity of enzymatically released peptides from soybean protein isolate. Eur. Food Res. Technol. 2009, 229, 637–644. [Google Scholar] [CrossRef]
- Huang, W.-Y.; Majumder, K.; Wu, J. Oxygen radical absorbance capacity of peptides from egg white protein ovotransferrin and their interactions with phytochemicals. Food Chem. 2010, 123, 635–641. [Google Scholar] [CrossRef]
- Liu, R.; Zheng, W.; Li, J.; Wang, L.; Wu, H.; Wang, X.; Shi, L. Rapid identification of bioactive peptides with antioxidant activity from the enzymatic hydrolysate of Mactra veneriformis by UHPLC–Q-TOF mass spectrometry. Food Chem. 2015, 167, 484–489. [Google Scholar] [CrossRef]
- Cheng, Y.; Chen, J.; Xiong, Y.L. Chromatographic separation and tandem MS identification of active peptides in potato protein hydrolysate that inhibit autoxidation of soybean oil-in-water emulsions. J. Agric. Food Chem. 2010, 58, 8825–8832. [Google Scholar] [CrossRef]
- Suetsuna, K.; Chen, J.-R. Isolation and characterization of peptides with antioxidant activity derived from wheat gluten. Food Sci. Technol. Res. 2002, 8, 227–230. [Google Scholar] [CrossRef] [Green Version]
- Saito, K.; Jin, D.-H.; Ogawa, T.; Muramoto, K.; Hatakeyama, E.; Yasuhara, T.; Nokihara, K. Antioxidative properties of tripeptide libraries prepared by the combinatorial chemistry. J. Agric. Food Chem. 2003, 51, 3668–3674. [Google Scholar] [CrossRef]
- Tian, M.; Fang, B.; Jiang, L.; Guo, H.; Cui, J.; Ren, F. Structure-activity relationship of a series of antioxidant tripeptides derived from β-lactoglobulin using QSAR modeling. Dairy Sci. Technol. 2015, 95, 451–463. [Google Scholar] [CrossRef]
- Suetsuna, K.; Ukeda, H. Isolation of an octapeptide which posseses active oxygen scavenging activity from peptic digest of sardine muscle. Nippon Suisan Gakkaishi (Jpn. Ed.) Bull. Jpn. Soc. Sci. Fish. 1999, 65, 1096–1099. [Google Scholar] [CrossRef]
- Yokomizo, A.; Takenaka, Y.; Takenaka, T. Antioxidative activity of peptides prepared from Okara protein. Food Sci. Technol. Res. 2002, 8, 57–359. [Google Scholar] [CrossRef] [Green Version]
- Ma, Y.; Xiong, Y.L.; Zhai, J.; Zhu, H.; Dziubla, T. Fractionation and evaluation of radical scavenging peptides from in vitro digests of buckwheat protein. Food Chem. 2010, 118, 582–588. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Torkova, A.; Kononikhin, A.; Bugrova, A.; Khotchenkov, V.; Tsentalovich, M.; Medvedeva, U. Effect of in vitro gastrointestinal digestion on bioactivity of poultry protein hydrolysate. Curr. Res. Nutr. Food Sci. 2016, 4, 77–86. [Google Scholar] [CrossRef]
- Marmouzi, I.; Karym, E.M.; Saidi, N.; Meddah, B.; Kharbach, M.; Masrar, A.; Bouabdellah, M.; Chabraoui, L.; El Allali, K.; Cherrah, Y.; et al. In vitro and in vivo antioxidant and anti-hyperglycemic activities of Moroccan oat cultivars. Antioxidants 2017, 6, 102. [Google Scholar] [CrossRef] [Green Version]
- Nwachukwu, I.D.; Aluko, R.E. Structural and functional properties of food protein-derived antioxidant peptides. J. Food Biochem. 2019, 43, 1–13. [Google Scholar] [CrossRef] [Green Version]
- Nimse, S.B.; Pal, D. Free radicals, natural antioxidants, and their reaction mechanisms. RSC Adv. 2015, 5, 27986–28006. [Google Scholar] [CrossRef] [Green Version]
- Zou, T.B.; He, T.P.; Li, H.B.; Tang, H.W.; Xia, E.Q. The structure-activity relationship of the antioxidant peptides from natural proteins. Molecules 2016, 21, 72. [Google Scholar] [CrossRef]
- Hernández-Ledesma, B.; Amigo, L.; Recio, I.; Bartolome, B. ACE-inhibitory and radicalscavenging activity of peptides derived from beta-lactoglobulin f(19-25). Interactions with ascorbic acid. J. Agric. Food Chem. 2007, 55, 3392–3397. [Google Scholar] [CrossRef]
- BIOPEP-UWM Database. Available online: http://www.uwm.edu.pl/biochemia/index.php/pl/biopep (accessed on 1 December 2019).
- UniProtKB. Available online: http://www.uniprot.org (accessed on 1 December 2019).
- UniProt Consortium. UniProt: A worldwide hub of protein knowledge. Nucleic Acids Res. 2019, 47, D506–D515. [Google Scholar] [CrossRef] [Green Version]
- Suetsuna, K. Separation and identification of antioxidant peptides from proteolytic digest of dried bonito. Nippon Suisan Gakkaishi 1999, 65, 92–96. [Google Scholar] [CrossRef] [Green Version]
- Xia, Y.; Bamdad, F.; Ganzle, M.; Chen, L. Fractionation and characterization of antioxidant peptides derived from barley glutelin by enzymatic hydrolysis. Food Chem. 2012, 134, 1509–1518. [Google Scholar] [CrossRef] [PubMed]
- Dziuba, J.; Iwaniak, A.; Minkiewicz, P. Computer-aided characteristics of proteins as potential precursors of bioactive peptides. Polimery 2003, 48, 50–53. [Google Scholar] [CrossRef] [Green Version]
- Nielsen, P.M.; Petersen, D.; Dambmann, C. Improved method for determining food protein degree of hydrolysis. J. Food Sci. 2001, 65, 642–646. [Google Scholar] [CrossRef]
- Minkiewicz, P.; Dziuba, J.; Michalska, J. Bovine meat proteins as potential precursors of biologically active peptides-A computational study based on the BIOPEP database. Food Sci. Technol. Int. 2011, 17, 39–45. [Google Scholar] [CrossRef] [PubMed]
Sample Availability: The amino acid sequences of proteins are available in the BIOPEP-UWM database (http://www.uwm.edu.pl/biochemia/index.php/pl/biopep). |
Protein Groups (nT) | NAAR* x (nc, f) (Range) | NAFS** x (Range) | A*** x (Range) | AAS**** (Antioxidant Activity) |
---|---|---|---|---|
I,IIAlpha-gliadins (21T, 20I + 1II) | 281 (16c + 2f) (259–318) | 14 (10–19) | 0.0498 (0.0314–0.0696) | LH (1)16, LHH (1)2, HL (1)12, AH (1)13 (2), HH (2)2 (3), EL (1)12, PYPQ (1) (2)11, (3)5 (5), LHQ (1)14, LWQ (1)14, IR (1)18, TY (1)16, VY (1)18, LW (1)14, LLR (1)2, YQL (1)16, QYP (1)16 (2)2, KYL, RW, AY, LY, HHH (1)2 (2), PHQ (1)2, QHH |
IAlpha/beta-gliadins (12T)***** | 287 (10c + 1f) (186–319) | 13 (10–19) | 0.0463 (0.0313–0.0653) | LH (1)8, LHH, HL (1)3, AH (1)8 (2), HH (2) (3), EL (1)3, PYPQ (2) 2 (3) 7 (5), LHQ (1)7, LWQ (1)7, IR (1)11, TY (1)10, VY (1)10, LW (1)7, YQL (1)9, QYP (1)9 (2)2, QHH, HHH (1), (2), AY, PHQ, FC, KYL, MY |
IGamma-gliadins (32T)****** | 276 (21c + 8f) (203–337) | 10 (2–13) | 0.0349 (0.0078–0.0476) | HL, AY (1)2, LY (1)11, IY (1)2, AH (1)4, PHQ (1)7 (2)19, PWQ, PW (1)4, IR (1)21 (2)6, SVNVPL (1)2, LWS (1)20, AQIPQQ (1)23, KP (1)20, VY (1)23, LW (1)21, VYV (1)23, LWQ, RYQ, MHI (1)11, TY (1)5, VPW (1)3, PYPQ (1)12, HH, FHH, LK (1)3, FC, YLL (1)4 |
III,IVGamma-gliadins (6T, 4III+2IV) | 265 (6f) (244–283) | 12 | 0.0455 (0.0424–0.0492) | LY (1)6, PYPQ (1)6, LWS (1)6, PHQ (2)6, AQIPQQ (1)6, IR (1)6, KP (1)6, VY (1)6, LW (1)6, VYV (1)6, MHI (1)6 |
IOmega-gliadins (3T) | 280 (1c) | 8 | 0.0286 | EL (3), PYPQ (2), PWQ, PEL, PW |
IGlutenin, HMW subunits (12T) | 734 (12c) (462–973) | 28 (16–43) | 0.0372 (0.0242–0.0477) | LQPGQGQQ (2)5, LQPGQGQQG (2)5, GYY (9)5 (10) (12) (17)2 (18) (20) (22), EL (1)5 (2)3 (3)4, WY (1)7 (2), WYY (1)7 (2), RYY (1)6, YYL (1) (2)5, YYS (1)5, SYY (1)11, PWY (1)4, PW (1)10, LK (2)2 (3)4, WG (1)12, ACQ (1)4, PWS (1)6, MM, LH, HL, PYY, LHQ, RHY, QYP (4), LWG (1)2, PHQ (1)2, KP (1)2 (2), LW (1)2, IY, YYI, YYQ, PHY, RHV, IR, EYY |
IGlutenin, HMW subunits (21T) | 178 (1c + 19f) (101–238) | 9 (3–16) | 0.0471 (0.0142–0.0672) | LQPGQGQQ, LQPGQGQQG, GYY (1)4 (2)8 (3)3 (6) (7), LK (1)5 (2)4 (3), EL (1)7 (2)3 (3)5, RYY (1)9 (2)2, SYY (1)10, WG (1)13, ACQ (1)7, PWS (1)4, PW (1)5, AY (1)2, LLR (1)6, YYL (1)2 (2)2, LWQ, EYY (1)2, LWG (1)2, PWQ, LW (1)3, WY (1)2, WYY (1)2, YYS, AW, PYY |
I,VGlutenin, LMW subunits (57T, 54I+2V) | 319 (43c + 13f) (212–392) | 9 (3–17) | 0.0278 (0.0131–0.0466) | LY (1)51, AH (1)18, IY (1)24, RHE (1)12, IQY (1)12, IR (1)55, VY (1)29 (2)6, AY (1)27, PHQ (1)41 (2)9, PWQ (1)23, PW (1)23, SVNVPL (1)32, TY (1)8, LRTLPM (1)3, MM (1)5, LPM (1)5, PHK, WY (1)4, LWQ (1)4, LWY (1)4, KP (1)10, LW (2)4, HL (1)15, LH (1)3, HH (1)8 (2)4, GPP (1)3, EL (1)2 (2), SHH (1)10, HHH (1)4, LHN (1)2, PHL, RHQ, LHQ, THH |
IEnzyme inhibitors (10T) | 135 (9c) (121–168) | 7 (4–11) | 0.0548 (0.0280–0.0887) | LY (1)5, EL (1)4 (2)3, YCY (1)2, KD (1)5, LK (1)3, HL, LLPH, IY, YVL, KP, LW, LWI, PW (1)4, YVE, AH, MY (1)2, VKL (1)3, VVKL (1)2, AY (1) (2)2, LLR, CGA (1)2, PWS, VY, GYY (1)2, YYL (1)2, PEL (1)2, TY (1)2, EQC (1)2 |
IThaumatin-like proteins (3T) | 167 (3c) (154–173) | 5 (2–8) | 0.0308 (0.0116–0.0519) | AY (1)2, FC (1)3, LK, TW, VW (3), WG, HHP, YHH, HH, PHG |
IOther (13T, 12I+1VI) | 173 (6c + 2f) (118–253) | 9 (4–16) | 0.0474 (0.0294–0.0632) | AY (1) (2), LY (1)3, FC (1)4 (2)2, YVE (1)3, EQC, EL (1)2, VKL, VKV, LK (1)3 (3), KP (1)5, TY, VW (1)2, KD (1)5, YGY (1)2 (2), WG (2)3, CGA (2)3, GAA (1)2, MM (1)2, IY, PWV, KAI, KVI, VPW, PW, LKP |
*****ID 1365 (f120 NAAR, 13 NAFS, A = 0.1083, LH, HH (3), QHH, HHH (2), LHQ, LWQ, IR, VY, LW, QYP); ******ID 1364 (f146 NAAR, 14 NAFS, A = 0.0959, LH, HL (2), AY, LY, AH, EL, LHQ, LWQ, PHQ, TY, LW, YQL, SVNVPL) |
Protein Groups (nT) | NAAR* x (nc, f) (Range) | NAFS** x (Range) | A*** x (Range) | AAS**** (Antioxidant Activity) |
---|---|---|---|---|
IProlamins + globulins***** (11T) | 144 (9c + 2f*****) (101–174) | 7 (3–11) | 0.0470 (0.0297–0.0809) | AY (1)3, EL (1) (1)***** (4)*****, VW (1)5, LY (1)***** (1)3, RYY (1)3, RYQ, IY (1)6, YYG (1)3, YQL (1)7, WY (1)3, VY (1)***** (1) (2)2, LQGM (1)2, MM (1)***** (4)2, HL (1)***** (1)3, YYS, NYY, AH*****, PHW*****, RHL*****, GGE (1)2*****, LK (1)2*****, RHQ*****, IR*****, KP*****, PHL |
IGlutelins (16T) | 500 (7c) (496–510) | 28 (23–30) | 0.0551 (0.0461–0.0602) | LLPH (1)2, AY (1)4 (2)2 (3), LY (1)5 (2)2, IY (1)4 (2)2, KHNRGDEF, AH (2)6, (3), EL (1)3 (2)2 (3) (4), PHY (1)2, VKV (1)2, KD, IR (1)6 (2), LK (1) (2)2 (3)3, TY (1)3 (2) (3)2, VY (1) (2)2 (3) (4) (5)2, FC (1)2 (2)4, VYV (1)3, HL (1)5, HH, IKK, QHH, YRY, RHR, YVY (1)3, QYY (1)3, PWH (1)4, PWN, PW (1)4, RW (1)3, LKP (1)3, KP (1)4, MY (1) (2), RYQ, LLR, FLPE, RHI, RWN (1)2, EAK, LH (2), AHK, EYY, YYN, YSY, LHQ (2), PHG, PHW, RHV, TW, AW, LPM |
IOryzains + IIexpansin -B1****** (4T, 3I+1II) | 390 (4c) (267–471) | 21 (18–23) | 0.0554 (0.0467–0.0749) | AY (1)****** (1)2, LY (1) (2), AH (1) (2), EL (1)****** (1) (2) (3), RHD, GGE (1)****** (1), KD (2)2 (4) (5)******, LK (1) (2)****** (2)2, KP (1)2 (2) (3)******, VW, LW, DHG (1)2, WG (1)****** (2) (3)2, MM, CLV, IY, YEY, YYT, NYY, YCY, PHE, TY, AW, RHG, MY, VKV, IR, VY (1)****** (1), NHAV, GAA, GPP (1)****** (1), LAC******, WY******, EAK******, TW****** |
ILectin + oleosins (3T) | 182 (3c) (148–227) | 6 (5–7) | 0.0312 (0.0291–0.0338) | EL (2), WG, YGY, PHN, FC (2), YKY, MY, LK, MM, KYL, AH (2), YYQ, QYY, YVE |
IGlycine-rich proteins + other1 (9T) | 161 (9c) (135–183) | 7 (3–14) | 0.0427 (0.0185–0.0795) | YGY (6), KVI, HL, HH, AH, GHH, GGE (2), GAH, GAA (1)2 (2), EL (1)5, PHR, KD (1)2, IR (1) (3), KP (1)2, ELLI, FKK, YYV, SYY, PHV, PWG, YVL, PW, VY, AW (1)3, WG (1)2, TY (1)4, AY, TW, VW (2), FC, LH, LHN, VKL, LTC, LPM, PHA, PHN |
IAllergenic proteins + homolog protein + IIprofilin (13T, 12I + 1II) | 145 (8c+4f) (109–166) | 8 (3–18) | 0.0566 (0.0275–0.1259) | HH (1)8, YHH, IY (1)11, AH, EL (1)8 (2) (3), DHH (1)6, MY (1)5, KD (1)5, VY (1)7, FC (1)11, DHHQ (1)2, RHE, RWT, RW, DHHQVYSPGEQ, TY (1)3, VW (1)2, CGA, EQC, LH, HL (1) (2), YYN, LY (3), LYY, YLY, LHS, PHD, RWW, IRW, RW (1)2, IR (1)2, GHH, KP |
ITubulin chains (5T) | 451 (5c) (444–469) | 19 (14–21) | 0.0413 (0.0311–0.0473) | AY, LY (1)5, IY (2), AH, LH (1) (3)3, EL (1) (2)3, WY (1)4, RHG, MY (2), KD (2)2, TY (1)2, MM (1) (2)3, HL (1)3 (2), YYN (1)3, VYY (1)3, LHF (1)3, LHI (1)3, LHW (1)3, RHG (1)3, PEL (1)3, IR (1)3 (3), LK (1)2, (2)2, VY (1)3, LHL, RHL, WG (2), KCL, YLL |
IGermin-like proteins (6T) | 214 (5c + 1f) (181–225) | 9 (5–16) | 0.0403 (0.0231–0.0751) | LY (1)4 (2)2, PHQ, PHT (1)3, KP (1)2 (2)2, WEN, FC (1)3 (2), EL (1)3, HIH, PHI, KVI (1)2, LK (1)4, YLL, HVH, PHV, PHK, VKL, LWV, LW, LH (2), AY, YQY, LHT, LHY, PAGY, VY, TDY, LLPF, MM, LTC |
I,IIEnzymes + other2 (18T) | 875 (16c) (571–990) | 58 (42–88) | 0.0674 (0.0446–0.0892) | ADGF (1)7, AH (1)2 (2)7 (3)5, AHH, AW (1)9 (2)4, AY (1)6 (2)4 (3)3 (4), AYY (1)2, CGA (1)2, CME (1)2, DHG, EL (1)2 (2)3 (3)4 (4)3 (5)2 (6), EAK (1)2, ECA (1)2, FC (1)9 (2)4, FKK, GAA (1) (2)2, GAH, GPP, GHH (1)2, GGE (1)2, GYY (2)2, GGRP (1)5, GEC, GTW, GAWA, HH (1)7 (2)2 (3), HL (1) (2)4 (3)6 (4) (5) (6) (8), HHH (1)2, HHP (1)2, HLH (1)3, HHW (1)2, HVH (1)2, HHY, IHH, IY (1)6 (2)4 (3)4, IR (1)2 (2)4 (3)3 (4)2 (5) (7) (8), IKL (1)6, IKK (1)3, IQY (1)2, IYY (1)2, KCL (1)3, KD (1) (2)4 (3)4 (4)4 (6), KP (1)5 (2)6 (3) (4) (5), KYL (1)3, KVI (1)2, LHA (1)2, LHD (2)2, LHE (1)2, LAC (1)2, LDY, LFC, LHV, LH (1) (2)5 (3) (4)2 (5)2 (6) (7), LHH (1)2, LHF (1)2, LHI (1)2, LHL (1)7 (2), LHS (1)2, LLR (1)2, LK (2) (3)3 (5)5 (6)3 (7) (8)2, LW (1)3 (2)2, LWA (1)2, LHT (1)2, LWG (1)3, LY (1)5 (2)4 (3)3 (4)3, LHQ, LKP (1)6, LHG (1)4 (2), LARL, LWK, LWD, LHK (1)3, LHM (1)3, MM (1)7, MY (1)3 (2)8, PHD, PHE (1)2, PHG (1)3, PHN, PHL (1)2, PWL, PHV, PWE, PWQ (1)4, PWV (1)2, PW (1)9, PWS, RHF, RHR (1)2, RHS, RW (1)6 (2)2 (3), RWW (1)2, RHQ (1)2, RWA (1)3, RWG (1)2, RWI, RHL (1)2, RHK, RHD (1)8, RWE, RHG (1)3, SWN (1)2, SHH (1)2, SYY (1)2, TY (1)3 (2)4 (3)5 (5), TW (1)3 (2), THH (1)2, WG (1)6 (2) (3)2, WPL, VHH, VKL (1)4 (2), VW (1)6, VKV (1)3, VKP (1)8 (2), VVKL (1)2, YVL (1)2, VY (1)5 (2) (3)6 (4)2, YYL (2)2, YLL (1)3, QHH, QYY (1)2, YYA (1)2, YYD, YYQ (1)2, YKY (1)2, YRY (1)2, YYG, YDD, YLY (2)2, YHH, YYR |
IActins + other3 (23T) | 355 (20c + 2f) (202–514) | 26 (15–40) | 0.0734 (0.0453–0.1217) | AHK, AH (1)5 (2)4, ADF, AGDDAPR (1)3, AW (1)7 (2), AY (1)6 (2)5 (3)2 (5), CGA, CHI (1)2, DHH (1)2, DYK (1)2, EL (1)2 (2)8 (3)6 (4) (5)2 (6), ELLI, EAK, FC (1)3 (2), FYY (1)4, GAA (1)5 (2)4, GAH (1)2, CLV (1)2, HH (1)9 (7)2, HL (1)8 (2)3 (3)2, HHH (5)2, HHP (1)2, HLH, IHH, IY (1)9 (2)2 (6), IR (1)11 (2)5, IRW, IKL, KCL, KD (1)7 (2)5, KP (1)5 (2) (4)2, KKY, KVI, LAC (1)3, LDY (1)4, LFC (2), LHF (1)2 (3)2, LHV, LH (1)6 (2)3 (3)3, LHH, LHI, LHL (1)4, LHS (1)3, LHY, LLR (1)3 (2)2, LK (1)10 (2)2, LW (1)9 (2) (5), LWA (2), LHT, LWI (1) (2), LWH, LWG (1)3, LWR, LWY, LY (1)9 (2)6 (3)2, LVSK, MM (1)6, MY (1)6 (2), PEL (1)3, PHA (1)3, PHE, PHG (1)2, PHN (1)2, PHM, PW (1)6, PWA, PWG, PWS, PWI (1)3, RHN (1)2, RHI, RHS (1)3, RHY, RHT (1)3, RW (1)7 (2), RWL, SYY, TY (1)13, TDY, TERGY (1)4, TW (1)6, TFE, WDDMEK (1)4, WG (1)6 (2)3, WHH (1)4, WY (1)6, VAPEEHPV (1)2, VHH, VKL, VW (1)5 (2)5, VY (1)8 (2)4, VYV, YKY, YMY (1)2, YVL, YVGD (1)4, YYH (1)2, YYM, YYN, YYL, YQL, YHH (1)2, YAY, QCL (1)2, QHH |
I,IIOther4 (4T) | 330 (2c) (318–342) | 16 (13–18) | 0.0468 (0.0409–0.0526) | LH, AH (2), YYD, SYY, LHG, PWA, RHE, RHQ, MY, GGE (2), KD (1) (2), PW, VY, LLR, LAC, EL (3), WY, EAK, IR (2), LK (3), ALSAF, GAA |
Protein Groups (nT) | NAAR* x (nc, f) (Range) | NAFS** x (Range) | A*** x (Range) | AAS**** (Antioxidant Activity) |
---|---|---|---|---|
IHordeins (16T) | 334 (6c + 4f) (105–475) | 13 (7–44) | 0.0344 (0.0190–0.0614) | LY (1)3 (2)3, PHQ (1)8 (2) (15), PWQ (1)2 (3), PW (1)2 (2)2 (3), IR (1)4, LLPF (1)2, QCL, EL (1)3 (2)2, PYPQ (1)2 (2) (3)2, PHI, LK (1)2, KP (1)3, LPM (1)2, LWS, LW (1)2, RHE (1)3, IQY, VY (1)3, QKPFPQQPPF, PQIPEQF, LRTLPM, SVNVPL (1)2, MM, AH, GYY (4)2, PWS (2)2, LQPGQGQQ (1)2, LQPGQGQQG (1)2, TY, WG (1)2, ACQ (1)2, LH (2), LHH, HH, AY, LHQ, WYY, WY, YYG, LYY (2) |
IGlobulin***** + hordothionins + other1 (10T) | 197 (6c + 2f) (127–499) | 13 (2–45) | 0.0587 (0.0157–0.0902) | KP (1)2 (2)***** (2) (3), WG*****, LAC*****, HL (1) (3), IKK (1)2, IY (1)2, KD (1) (2), IR (1)2 (2), TY (1) (2) (3), VW, AY (2) (4), EL (1)2 (2), EAK, KAI (2), LK (1)3 (2)2, VKP, GAA (1) (2), HHP, LHH, LH (2), LLHH, HH, ADF, LY (1)4, AH, YEY, YGY, LHE, RWG (3), IRW (2), RW (4), WG (2) (5), FC (1)2 (2), VY (2), YVE, PWQ, PW, YAY, LHN, LHS |
ITubulin chains (4T) | 450 (4c) (447–451) | 16 (15–20) | 0.0362 (0.0333–0.0447) | AY (1) (2)2, LY (1)4, IY (1)2 (2), AH, EL (1)3 (2), WY (1)4, RHG (1)4, MY (2)3, KD (2)3, TY (1)2 (2), MM (1)3 (2), IR (1)3, VY (1)3, LH (3), HL, YYN, VYY, LHF, LHI, LHW, PEL, LK |
IThaumatin-like proteins (4T) | 214 (4c) (171–233) | 10 (8–13) | 0.0478 (0.0429–0.0575) | AY (1)4, EL (1)3, YSY (1)3, KVI, KD (1) (2) (3), TDY, TW (1)2, VW (1) (2)3, FC (1)2, LK (1)2, TY (1)2, LAC (1)2, VY, YLL, GGE, RYQ, WG, LPM |
IHordoindolines (14T) | 136 (14f) (103–142) | 10 (4–14) | 0.0773 (0.0282–0.1165) | LH (1)10, GYY (1)8, EL (1)10, YYW (1)8, LHD (1)10, RWW (1)8 (2)2, VKV (1)10, KVI (1)10, KD (1)10 (2)4, RW (1)8 (2)2, TW (1)6 (2)8, YLL (1)10, IR (1)4, QYP |
IEnzymes + other2 (11T) | 162 (6c + 3f) (103–245) | 8 (4–16) | 0.0530 (0.0272–0.1165) | EL (1)4 (2)4, YYQ, SYY, MY, KD (1)5 (2), VY (1)3, CGA, VKL, PW (1)3, MWC, YCY, LK (1)3, PWT, GPP, FC (2), YVE, LY (1)2, LWI, YVL, LW, FKK, AY, AH (1)3, YYV (1)2, NYY (1)2, RHV (1)2, YVL (1)2, IR (1)2 (2), AW, PHN, TY (1) (2), LH, LHI, HEH, HRH, PWE, RHR, RW, KP, IY |
Protein Groups (nT) | NAAR* x (nc, f) (Range) | NAFS** x (Range) | A*** x (Range) | AAS**** (Antioxidant Activity) |
---|---|---|---|---|
I12S + 11S globulins (5T) | 481 (4c + 1f) (313–551) | 20 (13–22) | 0.0421 (0.0380–0.0466) | HL (1)2 (2), HH (1)2, VHH (1)2, AY (1)2 (2)3, LY (1)5, AH (1)5, PWQ (1)4, KD (1)4, PW (1)4, IR (1) (2)4, LKP (1)5, LK (3)3 (4)2, KP (1)5, TY (1)5, VY (2)4, FC (1)2 (2)2, VYV (1)2, LH, IY (2)2, LHR |
IAvenins (9T) | 210 (4c) (182–222) | 4 (2–8) | 0.0166 (0.0090–0.0374) | VY (1)3, VYV (1)3, AY, EL (2), PW, LK (2), TW (2) |
IThaumatin-like pathogenesis- related proteins (4T) | 169 (4c) | 8 (8–9) | 0.0488 (0.0473–0.0533) | HHP (1)3, YHH (1)3, HH (1)3, AY (1)4, LK (1)3, VW (1)4, WG (1)4, FC (1)4, DYY, YYD, GGE, VY, TW |
IAvenoindolines + other (5T) | 148 (2c) | 10 (8–11) | 0.0642 (0.0541–0.0743) | GYY (1)2, WY, YYW (1)2, RWW (1)2, KD (1)2, RW (1)2, TW (1)2, IR, EL, EAK, KVI, GPP, YLL |
Protein Groups (nT) | NAAR* x (nc, f) (Range) | NAFS** x (Range) | A*** x (Range) | AAS**** (Antioxidant Activity) |
---|---|---|---|---|
I13S globulins + IIseed storage protein (6T, 5I + 1II) | 408 (5c + 1f) (191–565) | 18 (9–24) | 0.0460 (0.0353–0.0628) | HH (1)3, LY (2)3 (3)2, AH (1)6, EL (1)3 (2)3, FHH, PHR, PWR, RWN (1)4, PW (1)3, RW (1)4, IR (1)4, LK (1) (2) (3) (5)3, FC (1)5, PHH (1)2, LH (1)2, AY (1)3, LHE, PWQ (1)2, RHS, TY (1)2, LW, IKK, ADF, IY, PHW, HL, HEH, YYS, SYY, LHG, RHN, YVL, WPL, VY, AW, VW, VYV, YVE, KP |
ILegumin-like 13S + legumin-type protein (2T) | 232 (2f) (160–303) | 7 | 0.0334 (0.0231–0.0437) | PHH, HH (1)2, PWQ, RHS, PW (1)2, IR (1)2, LW, LY, FHH, PHR, PWR |
IVicilin-like protein (1T) | 140 (1c) | 4 | 0.0286 | EL (2), PHI, EAK |
I,IIIAllergenic protein + other1 (4T, 3I + 1III) | 188 (3c + 1f) (133–252) | 8 (6–11) | 0.0420 (0.0238–0.0578) | EL (1)2, MY, KD (1) (2), LK (1) (3), VY, TW, MM (3), EQC, AY (1)2, AH (1)2, LY (2), HYY, YYH, RWR, RW (1)2, IR (2), RWN, FC |
IVOmega-secalins***** + other2 (14T) | 357***** (1c) | 1***** | 0.0028***** | EL***** |
IVGlutenin,, HMW subunits (2T) | 734 (2c) (713–754) | 31 (25–36) | 0.0414 (0.0351–0.0477) | GYY (9) (18), EL (1) (2), EYY (2), RYY, YYI (1)2, YYL (2), YYS, SYY (1)2, LWG, PHQ, LK (3), KP (1)2, LW, WG (1)2, IY, YYQ, PHY, PWS, RHV, LQPGQGQQ (2), LQPGQGQQG (2), PW, IR |
VKafirins (3T) | 268 (3c) (267–269) | 14 (13–16) | 0.0523 (0.0483–0.0599) | LH (1)3, HL (1) (2)2, AY (5) (6) (8), AH (1)3, LHA (1)2, PHS (1)2, TY (1)2, LHT, LLR, LLPF (2), LPM, IR |
Protein Groups (nT) | Ficin (EC 3.4.22.3) | Stem Bromelain (EC 3.4.22.32) | Pepsin (pH > 2) (EC 3.4.23.1) | ||||||
---|---|---|---|---|---|---|---|---|---|
DHt (%)* x (nc, f) Range | AE** x Range | AAS- AP***** | DHt (%)* x (n) Range | AE** x Range | AAS- AP***** | DHt (%)* x (n) Range | AE** x Range | AAS- AP***** | |
NAP**** x Range | W*** x Range | NAP**** x Range | W*** x Range | NAP**** x Range | W*** x Range | ||||
IAlpha- gliadins (21T, 20I + 1II) | 27.87 (14c + 2f) 24.92–30.07 | 0.0044 0.0031–0.0105 | AH (1)2, EL (1)2, TY (1)16 | 31.85 (14c + 2f) 29.07–35.07 | 0.0042 0.0031–0.0073 | EL (1)2, YQL (1)16, IR | 66.35 (16c + 2f) 63.26–68.77 | 0.0064 0.0031–0.0077 | HL (1)12, VY (1)18, PHQ (1)2 |
1 1–3 | 0.0907 0.0532–0.2008 | 1 1–2 | 0.0853 0.0658–0.1426 | 2 1–2 | 0.1285 0.0532–0.154 | ||||
IAlpha/beta- gliadins (12T) | 27.02 (9c + 1f) 24.84–29.19 | 0.0036 0.0031–0.0054 | TY (1)10 | 33.01 (8c + 1f) 32.35–35.09 | 0.0036 0.0031–0.0054 | YQL (1)9 | 67.04 (10c + 1f) 64.75–68.87 | 0.0047 0.0031–0.0108 | HL (1)3, VY (1)10, PHQ |
1 | 0.0807 0.0521–0.1003 | 1 | 0.0811 0.0521–0.1003 | 1 1–2 | 0.1005 0.0521–0.1674 | ||||
IGamma- gliadins (32T) | 27.33 (3c + 2f) 24.58–30.03 | 0.0041 0.0033–0.0049 | AY (1)2, IR (1)3 | 33.64 (21c + 6f) 28.51–49.91 | 0.0045 0.0030–0.0072 | HL, IR (1)21 (2)6 | 64.44 (20c + 8f) 62.63–67.08 | 0.0090 0.0035–0.0119 | HL, IY (1)2, PHQ (1)6 (2)19, VY (1)22 |
1 | 0.1231 0.0831–0.1667 | 1 1–2 | 0.1452 0.0831–0.2521 | 2 1–3 | 0.2667 0.1655–0.6694 | ||||
III,IVGamma- gliadins (6T, 4III + 2IV) | - | - | - | 29.90 (6f) 29.28–31.21 | 0.0038 0.0035–0.0041 | IR (1)6 | 64.83 (6f) 63.95–65.60 | 0.0114 0.0106–0.0123 | PHQ (2)6, VY (1)6 |
- | - | - | 1 | 0.0832 0.0824–0.0842 | 3 | 0.2501 0.2494–0.2505 | |||
IOmega- gliadins (3T) | 24.01 (1c) | 0.0107 | EL (2), PEL | 26.16 (1c) | 0.0071 | EL, PEL | 65.23 (1c) | 0.0036 | PWQ |
3 | 0.3741 | 2 | 0.2483 | 1 | 0.1259 | ||||
IGlutenin, HMW subunits (12T) | 38.82 (12c) 38.07–41.03 | 0.0043 0.0031–0.0065 | EL (1)6 (2)6, WG (1)12, PWS (1)5, WY, IY | 41.02 (12c) 39.01–43.12 | 0.0058 0.0031–0.0087 | EL (1)6 (2)6, YYL (1) (2)5, YYS (1)5, WG (1)12, PWS (1)5 | 75.12 (12c) 73.70–76.72 | 0.0028 0.0021–0.0042 | PWY (1)4, WG (1)12, WY (1)4, PHY, RHY, HL, IY |
3 2–4 | 0.1248 0.0701–0.1860 | 4 2–6 | 0.1561 0.1197–0.1860 | 2 1–3 | 0.0827 0.0462–0.127 | ||||
IGlutenin, HMW subunits (21T) | 39.15 (1c + 14f) 35.83–41.98 | 0.0156 0.0084–0.0252 | EL (1)7 (2)8, WG (1)13, PWS (1)4 | 50.23 (1c + 16f) 42.92–58.82 | 0.0147 0.0045–0.0252 | EL (1)6 (2)8, WG (1)13, PWS (1)4, YYL (1)4, YYS | 69.40 (1c + 12f) 66.37–72.17 | 0.0065 0.0042–0.0110 | WG (1)13, WY (1)2 |
3 2–3 | 0.3213 0.1250–0.5000 | 3 1–4 | 0.2976 0.0828–0.5000 | 1 1–2 | 0.1229 0.0625–0.2222 | ||||
I,VGlutenin, LMW subunits (57T, 54I + 2V) | 29.03 (38c + 5f) 26.26–31.31 | 0.0054 0.0029–0.0094 | AH (1)10, IR (1)12, VY (1)17 (2)2, AY (1)27, WY (1)4, EL (1)2 | 38.18 (42c + 13f) 28.46–43.88 | 0.0038 0.0026–0.0072 | IR (1)55, HL (1)8, EL (1)2 | 67.41 (42c + 13f) 64.36–70.62 | 0.0085 0.0052–0.0142 | IY (1)24, VY (1)29 (2)6, PHQ (1)41 (2)9, HL (1)14, PHK, WY (1)4, PWQ (1)4, PHL |
2 1–3 | 0.1930 0.0768–0.4264 | 1 1–2 | 0.1346 0.0778–0.2229 | 3 2–4 | 0.3129 0.1535–0.4437 | ||||
IEnzyme inhibitors (10T) | 39.53 (7c) 34.51–43.06 | 0.0119 0.006–0.0242 | EL (1)3, IY, AY (1)2, AH, MY (1)2, PWS, VY | 54.16 (5c) 48.59–58.33 | 0.011 0.0069–0.0165 | HL, EL, PWS, YYL (1)2, PEL (1)2 | 59.97 (3c) 59.02–60.48 | 0.0070 0.0060–0.0081 | HL, IY, VY |
2 1–3 | 0.2213 0.1261–0.3340 | 1 1–2 | 0.2235 0.1660–0.2850 | 1 | 0.1529 0.1261–0.1667 | ||||
IThaumatin- like proteins (3T) | - | - | - | 52.94 (1c) | 0.0065 | WG | - | - | - |
- | - | 1 | 0.1252 | - | - | ||||
IOther (13T, 12I + 1VI) | 43.84 (4c + 1f) 36.11–48.72 | 0.0055 0.0040–0.0085 | TY, WG (1)3, EL | 56.75 (2c) 55.56–57.94 | 0.0063 0.0040–0.0085 | EL, PWV | 68.07 (4c) 65.41–70.24 | 0.0094 0.0079–0.0108 | WG (2)3, IY, VPW |
1 | 0.1013 0.0633–0.1433 | 1 | 0.1033 0.0633–0.1433 | 2 | 0.1811 0.1250–0.2512 |
Protein Groups (nT) | Ficin (EC 3.4.22.3) | Stem Bromelain (EC 3.4.22.32) | Pepsin (pH > 2) (EC 3.4.23.1) | ||||||
---|---|---|---|---|---|---|---|---|---|
DHt (%)* x (nc, f) Range | AE** x Range | AAS- AP***** | DHt (%)* x (nc, f) Range | AE** x Range | AAS- AP***** | DHt (%)* x (nc, f) Range | AE** x Range | AAS- AP***** | |
NAP**** x Range | W*** x Range | NAP**** x Range | W*** x Range | NAP**** x Range | W*** x Range | ||||
IProlamins + globulins****** (11T) | 40.62 (6c+ 1f******) 33.11-–52.59 | 0.0115 0.0067–0.0147 | IY (1)6, EL (1) (2)******, VY (1)3 | 54.41 (4c+2f******) 50.97–57.80 | 0.0114 0.0057–0.0294 | YYG (1)3, HL, WY, EL (1)****** (3)****** | 69.65 (7c + 1f******) 67.10–73.15 | 0.0118 0.0057–0.0256 | IY (1)6, VY (1)****** (1) (2)2, HL, PHL |
2 1–2 | 0.2389 0.1675–0.3988 | 2 1–3 | 0.1972 0.1109–0.3634 | 2 1–4 | 0.2902 0.1109–0.5982 | ||||
IGlutelins (16T) | 43.28 (7c) 42.63–44.06 | 0.0054 0.0039–0.0081 | EL (1)3, VY (1)4 (2)2 (3), IY (1)4, AY | 52.48 (7c) 50.90–54.81 | 0.0040 0.0020–0.0060 | EL (1)2 (2)2, HL (1)4, IR (1)4 | 69.26 (7c) 68.37–71.74 | 0.0106 0.0078–0.0121 | IY (1)4 (2)2, PHY (1)2, VY (1) (2)2 (3) (4) (5)2, HH, HL, PHG, IR (1)2 |
3 2–4 | 0.0979 0.0710–0.1434 | 2 1–3 | 0.0729 0.0364–0.1062 | 5 4–6 | 0.1916 0.1421–0.2169 | ||||
IOryzains + IIexpansin -B1******* (4T, 3I+1II) | 42.04 (4c) 40.64–43.49 | 0.0083 0.0044–0.0112 | EL (1)2, WG (1)******* (1) (2)2, MY, VY (1)******* (1), EAK******* | 52.69 (4c) 47.74–59.28 | 0.0061 0.0037–0.0087 | DHG (1)2, WG (1)******* (1) (2) (3), EL | 68.67 (4c) 67.31–71.43 | 0.0054 0.0042–0.0075 | RHD, WG (1)3, IY, VY (1)******* (1), WY******* |
3 2–4 | 0.1489 0.0876–0.2213 | 3 1–4 | 0.1176 0.0494–0.1733 | 2 | 0.0971 0.0876–0.1107 | ||||
ILectin + oleosins (3T) | 42.48 (1c) | 0.0044 | EL | 50.89 (1c) | 0.0088 | EL (2) | 68.58 (1c) | 0.0044 | WG |
1 | 0.1429 | 2 | 0.2857 | 1 | 0.1429 | ||||
IGlycine-rich proteins + other1 (9T) | 58.30 (6c) 40.52–82.97 | 0.0105 0.0055–0.0148 | AH, IR (1) (2), EL (1)3, TY (1)3 | 65.39 (5c) 53.62–82.42 | 0.0115 0.0055–0.0222 | HH, EL (1)2, IR (1) (2), YYV, PWG, WG | 72.44 (3c) 63.43–84.62 | 0.0118 0.0109–0.0130 | HL, HH, PWG, VY, PHA, PHN |
2 1–2 | 0.3418 0.1259–0.6667 | 2 1–4 | 0.1998 0.1259–0.3744 | 2 | 0.2643 0.1434–0.4000 | ||||
I,IIAllergenic proteins + homolog protein + IIprofilin (13T) | 41.92 (7c + 4f) 39.23–45.77 | 0.0135 0.0070–0.0183 | EL (1)9 (2), IY (1)10 | 55.63 (7c + 4f) 39.44–59.82 | 0.0077 0.0060–0.0121 | EL (1)9 (2), IR | 62.02 (8c + 4f) 56.36–73.08 | 0.0126 0.0088–0.0180 | HL (1)2, PHD, IY (1)11, VY (1)7, RHE |
2 1–3 | 0.2934 0.0556–0.6655 | 1 1–2 | 0.1591 0.0556–0.3345 | 2 1–2 | 0.2520 0.1112–0.5000 | ||||
ITubulin chains (5T) | 41.68 (5c) 41.03–43.38 | 0.0058 0.0045–0.0089 | AY, WY (1)4, MY (2), IR (1)3 (2), WG | 51.30 (4c) 50.90–51.92 | 0.0061 0.0045–0.0107 | EL (1)3, PEL (1)3, HL (2), IR (2), KCL | 70.29 (5c) 68.15–71.33 | 0.0049 0.0044–0.0064 | IY (2), HL (1)4, VY (1)3, WG (2) |
3 2–4 | 0.1509 0.0951–0.2862 | 3 2–5 | 0.1468 0.0951–0.2956 | 2 2–3 | 0.1220 0.0951–0.1768 | ||||
IGermin-like proteins (6T) | 43.87 (1c) | 0.0094 | AY, EL | 58.55 (3c) 54.71–66.04 | 0.0045 0.0044–0.0047 | EL (1)3 | 69.02 (2c + 1f) 66.07–72.64 | 0.0049 0.0044–0.0055 | PHQ, PHK, VY |
2 | 0.1252 | 1 | 0.0926 0.0626–0.1236 | 1 | 0.1345 0.0626–0.1993 | ||||
I,IIEnzymes + other2 (18T) | 44.08 (16c) 41.44–48.18 | 0.0088 0.0032–0.0212 | AY (1)7 (2)2 (3)2 AH (1)9 (2)4, EL (1)8 (2)3 (4)2, PWS, IR (1)8 (3) (5)2, TY (1)8 (2)2 (3), WG (1)8 (2), VY (1)2 (2)4, IY (1)2 (2)3 (3), EAK (1)2 | 54.74 (16c) 49.82–59.67 | 0.0078 0.0012–0.0127 | HL (1)4 (2)6 (3)2 (4), EL (1)3 (2)8 (3), IR (1)3 (2)2 (3)3 (4)3 (5), DHG, WG (1)9 (2), YYG, YYA (1)2, YYL (1)2, PWL, IKL (1)5, KYL (1)3, WPL, PWV (1)2, YYR | 68.29 (16c) 64.05–71.73 | 0.0105 0.0073–0.0139 | HL (1) (2)7 (3)6 (4) (5), PHL (1)2, RHD, WG (1)6 (2)2 (3), IY (1)6 (2)4 (3)4, VY (1)6 (2) (3)6 (4)2, RHQ (1)2, PWL, RHK, SWN (1)2, WPL, HHY, PWE, RWG, IR (1)6, VHH, RWE, RHG (1)3, PW (1)2, PWQ (1)4, RW |
8 3–21 | 0.1258 0.0663–0.2468 | 7 1–12 | 0.1195 0.0171–0.2313 | 9 6–12 | 0.1604 0.1038–0.2222 | ||||
IActins + other3 (23T) | 45.13 (19c + 2f) 40.53–49.75 | 0.0101 0.0027–0.0175 | EL (1)11 (2)5 (3) TDY, AY (1)10, IR (1)3 (2)4, AH (1)3, VY (1)5 (2)2, TY (1)3, WG (1)4, IY (1)3, AW, WY, MY (1)3, PEL, PWG | 58.58 (19c + 2f) 49.73–69.66 | 0.0093 0.0027–0.0217 | PHA (1)3, IR (1)5 (2)4, HL (1)6 (2)3, EL (1)6 (2)4 (3)3 (4), YQL, WG (1)7 (2), PEL (1)2, YYL, PWG | 68.42 (19c + 2f) 62.82–70.91 | 0.0107 0.0030–0.0217 | IY (1)9 (2) (6), PHA (1)3, VW (1)2 (2)2 VY (1)8 (2)4, HL (1)5 (2)2 (3), PHN (1)2, WG (1)5 (2), PW, WY (1)2, IR, PHE, PHG (1)2, RHN (1)2, RW (1)2, PWG, IRW, RWL, PHM |
4 1–8 | 0.1429 0.0293–0.3333 | 3 1–7 | 0.1279 0.0406–0.2382 | 4 1–10 | 0.1504 0.0662–0.2382 | ||||
I,IIOther4 (4T) | 41.32 (2c) 37.54–45.11 | 0.0061 0.0058–0.0063 | AY, MY, EL, IR | 56.15 (1c) | 0.0063 | EL, IR | 71.30 (2c) 70.67–71.92 | 0.0030 0.0029–0.0031 | VY, WY |
2 | 0.1322 0.1103–0.1540 | 2 | 0.1540 | 1 | 0.0655 0.0551–0.0758 |
Protein Groups (nT) | Ficin (EC 3.4.22.3) | Stem Bromelain (EC 3.4.22.32) | Pepsin (pH>2) (EC 3.4.23.1) | ||||||
---|---|---|---|---|---|---|---|---|---|
DHt (%)* x (nc, f) Range | AE** x Range | AAS- AP***** | DHt (%)* x (n) Range | AE** x Range | AAS- AP***** | DHt (%)* x (n) Range | AE** x Range | AAS- AP***** | |
NAP**** x Range | W*** x Range | NAP**** x Range | W*** x Range | NAP**** x Range | W*** x Range | ||||
IHordeins (16T) | 35.22 (3c + 1f) 28.42–41.14 | 0.0041 0.0034–0.0053 | EL (1)3, PQIPEQF, PWS (1)2, AY, WY | 37.76 (5c + 3f) 23.08–48.81 | 0.0048 0.0033–0.0095 | IR (1)4, EL (1)4, PWS (1)2, YYG | 64.51 (6c + 3f) 60.58–69.79 | 0.0074 0.0013–0.0129 | PWQ (1)2 (3), PHQ (1)6, RHE (1)3, VY (1)3, WY |
2 1–4 | 0.0994 0.0554–0.1264 | 1 1–3 | 0.1635 0.0688–0.5000 | 2 1–3 | 0.2534 0.0224–0.5022 | ||||
IGlobulin****** + hordothionins + other1 (10T) | 43.26 (3c + 2f) 34.83–48.53 | 0.0188 0.0076–0.0274 | IY, AY (2)2, EL (1) (2), ADF, AH, TY (2)2, VY, WG (1) (5), PWG | 56.30 (3c + 1f) 46.92–63.48 | 0.0113 0.0068–0.0153 | HL, IR (1) (2), EL (1) (2), WG (3), PWG | 69.29 (4c) 66.37–71.54 | 0.0171 0.0045–0.0382 | WG (1)****** (1) (2), HL (1) (3), IY (1)2, VW, VY (2), PWG |
4 1–11 | 0.2383 0.0996–0.2661 | 3 1–6 | 0.1416 0.0993–0.2005 | 4 1–6 | 0.2713 0.1330–0.5007 | ||||
ITubulin chains (4T) | 42.22 (4c) 40.81–43.56 | 0.0106 0.0045–0.0133 | AY (1) (2)2, WY (1)4, MY (2)3, IR (1)3, TY | 52.82 (3c) 51.57–53.56 | 0.0030 0.0022–0.0045 | IR (1)2, EL, PEL | 69.36 (4c) 68.60–70.40 | 0.0044 0.0044–0.0045 | IY (1)2 (2), VY (1)3, HL |
5 2–6 | 0.3082 0.1007–0.3994 | 1 1–2 | 0.0776 0.0661–0.1007 | 2 | 0.1243 0.1007–0.1321 | ||||
IThaumatin- like proteins (4T) | 41.91 (2c) 41.33–42.48 | 0.0044 | EL (1)2 | - | - | - | 71.11 (1c) | 0.0044 | VY |
1 | 0.0882 0.0765–0.0998 | - | - | 1 | 0.0765 | ||||
IHordoindolines (14T) | 43.83 (5f) 42.55–46.08 | 0.0075 0.0070–0.0097 | EL (1)5 | 51.63 (13f) 50.98–52.48 | 0.0089 0.0070–0.0141 | EL (1)4, YYW (1)8, IR (1)4 | - | - | - |
1 | 0.0768 0.0710–0.0833 | 1 1–2 | 0.1433 0.0765–0.2482 | - | - | ||||
IEnzymes + other2 (11T) | 41.23 (3c + 3f) 34.46–47.52 | 0.0149 0.0066–0.0291 | EL (1)3 (2)2, MY, VY, AY, AH (1)2, TY | 54.79 (5c + 1f) 50.68–63.70 | 0.0091 0.0041–0.0194 | EL (1)5, PWT, IR (1)2 | 63.48 (3c + 3f) 60–70.49 | 0.0081 0.0066–0.0122 | VY (1)3, PWT, PHN, IR, IY, PWE |
2 1–4 | 0.2782 0.1248–0.5000 | 1 1–2 | 0.1618 0.0628–0.2500 | 1 1–3 | 0.1646 0.0833–0.2006 |
Protein Groups (nT) | Ficin (EC 3.4.22.3) | Stem Bromelain (EC 3.4.22.32) | Pepsin (pH>2) (EC 3.4.23.1) | ||||||
---|---|---|---|---|---|---|---|---|---|
DHt (%)* x (nc, f) Range | AE** x Range | AAS- AP***** | DHt (%)* x (n) Range | AE** x Range | AAS- AP***** | DHt (%)* x (n) Range | AE** x Range | AAS- AP***** | |
NAP**** x Range | W*** x Range | NAP**** x Range | W*** x Range | NAP**** x Range | W*** x Range | ||||
I12S + 11S globulins (5T) | 42.77 (4c) 42.40–43.33 | 0.0019 0.0018–0.0020 | VY (1)4 | 50.59 (4c + 1f) 49.04–52.18 | 0.0040 0.0019–0.0064 | HL (1)2 (2), IR (1)3 (2) | 71.13 (4c + 1f) 69.55–71.82 | 0.0105 0.0064-0.0121 | HL (1)3, VY (2)4, VHH (1)2, PWQ (1)4, IR (1)5, IY (2)2 |
1 | 0.0452 0.0428–0.0500 | 2 1–2 | 0.0936 0.0500–0.1542 | 5 2–6 | 0.2497 0.1542–0.3000 | ||||
IAvenins (9T) | 45.07 (1c) | 0.0047 | EL | 52.11 (1c) | 0.0047 | EL | 71.24 (3c) 69.61–72.60 | 0.0048 0.0045–0.0055 | VY (1)3 |
1 | 0.1257 | 1 | 0.1257 | 1 | 0.4982 0.4945–0.5000 | ||||
IThaumatin-like pathogenesis- related proteins (4T) | - | - | - | - | - | - | 68.45 (1c) | 0.0059 | VY |
- | - | - | - | 1 | 0.1107 | ||||
IAvenoindolines + other (5T) | 46.26 (1c) | 0.0135 | WY, IR | 50.68 (2c) 50.34–51.02 | 0.0102 0.0068–0.0135 | YYW (1)2, IR | 65.99 (1c) | 0.0068 | WY |
2 | 0.2495 | 2 1–2 | 0.1705 0.0915–0.2495 | 1 | 0.1257 |
Protein Groups (nT) | Ficin (EC 3.4.22.3) | Stem Bromelain (EC 3.4.22.32) | Pepsin (pH > 2) (EC 3.4.23.1) | ||||||
---|---|---|---|---|---|---|---|---|---|
DHt (%)* x (nc, f) Range | AE** x Range | AAS- AP***** | DHt (%)* x (n) Range | AE** x Range | AAS- AP***** | DHt (%)* x (n) Range | AE** x Range | AAS- AP***** | |
NAP**** x Range | W*** x Range | NAP**** x Range | W*** x Range | NAP**** x Range | W*** x Range | ||||
I13S globulins + IIseed storage protein (6T, 5I + 1II) | 44.85 (4c + 1f) 42.49–46.32 | 0.0042 0.0190–0.0066 | PWR, IR (1)4, EL (1)2, IY, VY | 55.48 (4c + 1f) 54.87–57.37 | 0.0053 0.0037–0.0071 | EL (1)4, PHR, PWR, IR (1)3, HL, YYS, WPL | 68.15 (2c + 1f) 64.80–71.50 | 0.0053 0.0019–0.0088 | PWQ, HL, RHN, WPL, VY |
2 1–3 | 0.0969 0.0840–0.1358 | 2 1–4 | 0.1216 0.0828–0.2006 | 2 1–4 | 0.1157 0.0538–0.1811 | ||||
ILegumin- like 13S + legumin- type protein (2T) | 44.69 (2f) 44.03–45.36 | 0.0065 0.0063–0.0066 | IR (1)2, PWR | 52.46 (2f) 50.94–53.97 | 0.0081 0.0063–0.0099 | IR (1)2, PHR, PWR | - | - | - |
2 1–2 | 0.2150 0.1442–0.2857 | 2 1–3 | 0.2864 0.1442–0.4286 | - | - | ||||
IVicilin-like protein (1T) | 43.88 (1c) | 0.0214 | EL (2), EAK | 51.80 | 0.0071 | EL | - | - | - |
3 | 0.7483 | 1 | 0.2483 | - | - | - | |||
I,IIIAllergenic proteins + other (4T, 3I + 1III) | 44.82 (2c) 43.02–46.61 | 0.0885 0.0040–0.1730 | EL, AY, AH, IR | 54.12 (1f) | 0.0051 | EL | 74.98 (2c) 72.67–77.29 | 0.0049 0.0040–0.0058 | VY, RWR |
2 1–3 | 0.2337 0.1681–0.2993 | 1 | 0.0904 | 1 | 0.1342 0.1003–0.1681 | ||||
IVOmega- secalins + other (14T) | - | - | - | - | - | - | - | - | - |
- | - | - | - | - | - | - | |||
IVGlutenin,, HMW subunits (2T) | 38.22 (2c) 37.92-38.51 | 0.0048 0.0040–0.0056 | IY, EL (1) (2), PWS, WG (1)2 | 40.00 (2c) 39.84–40.17 | 0.0061 0.0042–0.0080 | EL (1) (2), PWS, WG (1)2, YYL (2), YYS | 75.15 (2c) 75.00–75.30 | 0.0028 0.0013–0.0042 | WG (1)2, IY, PHY |
4 3–4 | 0.1217 0.0839–0.1595 | 5 3–6 | 0.1437 0.1197–0.1677 | 2 1–3 | 0.0735 0.0273–0.1197 | ||||
VKafirins (3T) | 32.13 (3c) 30.97–32.71 | 0.0050 0.0037–0.0075 | AH (1)3, AY | 53.00 (3c) 51.49–54.89 | 0.0050 0.0037–0.0075 | HL (1)3, IR | 77.37 (3c) 76.69–78.36 | 0.0062 0.0037–0.0075 | HL (1) (2)2 |
1 1–2 | 0.0926 0.0760–0.1252 | 1 1–2 | 0.0692 0.0618–0.1540 | 2 1–2 | 0.1075 0.0618–0.1540 |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Szerszunowicz, I.; Kłobukowski, J. Characteristics of Potential Protein Nutraceuticals of Plant Origin with Antioxidant Activity. Molecules 2020, 25, 1621. https://doi.org/10.3390/molecules25071621
Szerszunowicz I, Kłobukowski J. Characteristics of Potential Protein Nutraceuticals of Plant Origin with Antioxidant Activity. Molecules. 2020; 25(7):1621. https://doi.org/10.3390/molecules25071621
Chicago/Turabian StyleSzerszunowicz, Iwona, and Jan Kłobukowski. 2020. "Characteristics of Potential Protein Nutraceuticals of Plant Origin with Antioxidant Activity" Molecules 25, no. 7: 1621. https://doi.org/10.3390/molecules25071621
APA StyleSzerszunowicz, I., & Kłobukowski, J. (2020). Characteristics of Potential Protein Nutraceuticals of Plant Origin with Antioxidant Activity. Molecules, 25(7), 1621. https://doi.org/10.3390/molecules25071621